413 related articles for article (PubMed ID: 11423095)
1. Toxic effects of MPP(+) and MPTP in PC12 cells independent of reactive oxygen species formation.
Fonck C; Baudry M
Brain Res; 2001 Jun; 905(1-2):199-206. PubMed ID: 11423095
[TBL] [Abstract][Full Text] [Related]
2. Release of dopamine by perfusion with 1-methyl-4-phenylpyridinium ion (MPP(+)) into the striatum is associated with hydroxyl free radical generation.
Obata T; Yamanaka Y; Kinemuchi H; Oreland L
Brain Res; 2001 Jul; 906(1-2):170-5. PubMed ID: 11430875
[TBL] [Abstract][Full Text] [Related]
3. D-deprenyl protects nigrostriatal neurons against 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced dopaminergic neurotoxicity.
Muralikrishnan D; Samantaray S; Mohanakumar KP
Synapse; 2003 Oct; 50(1):7-13. PubMed ID: 12872288
[TBL] [Abstract][Full Text] [Related]
4. Prevention of 1-methyl-4-phenylpyridinium- and 6-hydroxydopamine-induced nitration of tyrosine hydroxylase and neurotoxicity by EUK-134, a superoxide dismutase and catalase mimetic, in cultured dopaminergic neurons.
Pong K; Doctrow SR; Baudry M
Brain Res; 2000 Oct; 881(2):182-9. PubMed ID: 11036157
[TBL] [Abstract][Full Text] [Related]
5. Attenuation of 1-methyl-4-phenylpyridinium (MPP+) neurotoxicity by deprenyl in organotypic canine substantia nigra cultures.
Schmidt DE; Ebert MH; Lynn JC; Whetsell WO
J Neural Transm (Vienna); 1997; 104(8-9):875-85. PubMed ID: 9451719
[TBL] [Abstract][Full Text] [Related]
6. Antioxidant mechanism and protection of nigral neurons against MPP+ toxicity by deprenyl (selegiline).
Wu RM; Mohanakumar KP; Murphy DL; Chiueh CC
Ann N Y Acad Sci; 1994 Nov; 738():214-21. PubMed ID: 7832430
[TBL] [Abstract][Full Text] [Related]
7. Comparison of the time courses of selective gene expression and dopaminergic depletion induced by MPP+ in MN9D cells.
Wang J; Duhart HM; Xu Z; Patterson TA; Newport GD; Ali SF
Neurochem Int; 2008 May; 52(6):1037-43. PubMed ID: 18069091
[TBL] [Abstract][Full Text] [Related]
8. Chronic administration of pharmacological levels of melatonin does not ameliorate the MPTP-induced degeneration of the nigrostriatal pathway.
Morgan WW; Nelson JF
Brain Res; 2001 Dec; 921(1-2):115-21. PubMed ID: 11720717
[TBL] [Abstract][Full Text] [Related]
9. Therapeutic effects of multifunctional tetramethylpyrazine nitrone on models of Parkinson's disease in vitro and in vivo.
Guo B; Xu D; Duan H; Du J; Zhang Z; Lee SM; Wang Y
Biol Pharm Bull; 2014; 37(2):274-85. PubMed ID: 24305623
[TBL] [Abstract][Full Text] [Related]
10. Cytotoxicity of 1-amino-4-phenyl-1,2,3,6-tetrahydropyridine and 1-amino-4-phenylpyridinium ion, 1-amino analogues of MPTP and MPP+, to clonal pheochromocytoma PC12 cells.
Kohda K; Noda Y; Aoyama S; Umeda M; Sumino T; Kaiya T; Maruyama W; Naoi M
Chem Res Toxicol; 1998 Nov; 11(11):1249-53. PubMed ID: 9815183
[TBL] [Abstract][Full Text] [Related]
11. Monoamine oxidase-inhibition and MPTP-induced neurotoxicity in the non-human primate: comparison of rasagiline (TVP 1012) with selegiline.
Kupsch A; Sautter J; Götz ME; Breithaupt W; Schwarz J; Youdim MB; Riederer P; Gerlach M; Oertel WH
J Neural Transm (Vienna); 2001; 108(8-9):985-1009. PubMed ID: 11716151
[TBL] [Abstract][Full Text] [Related]
12. Elevated expression of glutathione peroxidase in PC12 cells results in protection against methamphetamine but not MPTP toxicity.
Hom DG; Jiang D; Hong EJ; Mo JQ; Andersen JK
Brain Res Mol Brain Res; 1997 Jun; 46(1-2):154-60. PubMed ID: 9191089
[TBL] [Abstract][Full Text] [Related]
13. The antioxidant ebselen prevents neurotoxicity and clinical symptoms in a primate model of Parkinson's disease.
Moussaoui S; Obinu MC; Daniel N; Reibaud M; Blanchard V; Imperato A
Exp Neurol; 2000 Dec; 166(2):235-45. PubMed ID: 11085889
[TBL] [Abstract][Full Text] [Related]
14. Transgenic mice with increased Cu/Zn-superoxide dismutase activity are resistant to N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced neurotoxicity.
Przedborski S; Kostic V; Jackson-Lewis V; Naini AB; Simonetti S; Fahn S; Carlson E; Epstein CJ; Cadet JL
J Neurosci; 1992 May; 12(5):1658-67. PubMed ID: 1578260
[TBL] [Abstract][Full Text] [Related]
15. The selective toxicity of 1-methyl-4-phenylpyridinium to dopaminergic neurons: the role of mitochondrial complex I and reactive oxygen species revisited.
Nakamura K; Bindokas VP; Marks JD; Wright DA; Frim DM; Miller RJ; Kang UJ
Mol Pharmacol; 2000 Aug; 58(2):271-8. PubMed ID: 10908294
[TBL] [Abstract][Full Text] [Related]
16. 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine has a transient proliferative effect on PC12h cells and nerve growth factor additively promotes this effect: possible involvement of distinct mechanisms of activation of MAP kinase family proteins.
Shimoke K; Kudo M
Brain Res Dev Brain Res; 2002 Feb; 133(2):105-14. PubMed ID: 11882341
[TBL] [Abstract][Full Text] [Related]
17. Differential effect of catecholamines and MPP(+) on membrane permeability in brain mitochondria and cell viability in PC12 cells.
Lee CS; Han JH; Jang YY; Song JH; Han ES
Neurochem Int; 2002 Apr; 40(4):361-9. PubMed ID: 11792467
[TBL] [Abstract][Full Text] [Related]
18. A new in vitro approach for investigating the MPTP effect on DA uptake.
Barc S; Page G; Fauconneau B; Barrier L; Huguet F
Neurochem Int; 2001 Mar; 38(3):243-8. PubMed ID: 11099783
[TBL] [Abstract][Full Text] [Related]
19. Genetic elevation of monoamine oxidase levels in dopaminergic PC12 cells results in increased free radical damage and sensitivity to MPTP.
Wei Q; Yeung M; Jurma OP; Andersen JK
J Neurosci Res; 1996 Dec; 46(6):666-73. PubMed ID: 8978500
[TBL] [Abstract][Full Text] [Related]
20. Rapid reduction of ATP synthesis and lack of free radical formation by MPP+ in rat brain synaptosomes and mitochondria.
Fonck C; Baudry M
Brain Res; 2003 Jun; 975(1-2):214-21. PubMed ID: 12763610
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
